"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this 12-part journey through a disease state ...

The burden of atopic dermatitis (AD) -- for patients, their families, and society -- is vast and increasing. AD affects approximately 10% to 30% of children and 2% to 10% of adults in developed ...

Atopic dermatitis is an allergy affecting approximately 10% of the Japanese population, with symptoms closely related to social stress. In socially active adults, the disease often becomes chronic. In ...

In a recent article published in Nature Communications, researchers investigated endotype-phenotype associations in atopic dermatitis (AD) beyond its general clinical severity. AD is highly ...

SHANGHAI, May 13, 2021 /PRNewswire/ -- Reistone Biopharma Company Limited (Reistone), a clinical stage biopharmaceutical company focused on developing novel medicines for autoimmune and inflammatory ...

Lawrence F. Eichenfield, MD, FAAD, from Rady Children's Hospital and UC San Diego School of Medicine, highlighted the effectiveness of ruxolitinib cream as a nonsteroidal topical treatment for atopic ...

Discover some of the new atopic dermatitis treatments in clinical development that could overcome existing challenges in the ...

Insomnia is linked to an 80% increased risk of atopic dermatitis, highlighting the importance of addressing sleep issues in allergic disease management. Mendelian randomization identified genetic ...